Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer
- DOI
- 10.1172/jci200438
- Published
- 2026-06-23
- Container
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci200438,
title = {Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer},
author = {Galina Semenova and Sander B. Frank and Ruth Dumpit and Wanting Han and Ilsa Coleman and Roman Gulati and Canan D. Dirican and Tarana Arman and Jessica Maruwan and Colm Morrissey and Michael C. Haffner and Peter S. Nelson and John K. Lee},
year = {2026},
journal = {Journal of Clinical Investigation},
doi = {10.1172/jci200438},
url = {https://doi.org/10.1172/jci200438}
}RIS
TY - JOUR TI - Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer AU - Galina Semenova AU - Sander B. Frank AU - Ruth Dumpit AU - Wanting Han AU - Ilsa Coleman AU - Roman Gulati AU - Canan D. Dirican AU - Tarana Arman AU - Jessica Maruwan AU - Colm Morrissey AU - Michael C. Haffner AU - Peter S. Nelson AU - John K. Lee PY - 2026 JO - Journal of Clinical Investigation DO - 10.1172/jci200438 UR - https://doi.org/10.1172/jci200438 ER -
APA
Semenova, G., Frank, S. B., Dumpit, R., Han, W., Coleman, I., Gulati, R., Dirican, C. D., Arman, T., Maruwan, J., Morrissey, C., Haffner, M. C., Nelson, P. S., & Lee, J. K. (2026). Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci200438
Source records
- crossref · retrieved 2026-09-27T07:42:16.244Z